TY - JOUR
T1 - A switch in the source of ATP production and a loss in capacity to perform glycolysis are hallmarks of hepatocyte failure in advance liver disease
AU - Nishikawa, Taichiro
AU - Bellance, Nadège
AU - Damm, Aaron
AU - Bing, Han
AU - Zhu, Zhen
AU - Handa, Kan
AU - Yovchev, Mladen I.
AU - Sehgal, Vasudha
AU - Moss, Tyler J.
AU - Oertel, Michael
AU - Ram, Prahlad T.
AU - Pipinos, Iraklis I.
AU - Soto-Gutierrez, Alejandro
AU - Fox, Ira J.
AU - Nagrath, Deepak
N1 - Funding Information:
This work was supported by grants from NIH, DK48794 and DK09932 to I.J.F.; DK083556 to A.S.-G.; AG034995 to I.I.P.; and DK090325 to M.O.; U54-CA112970 to P.T.R. and Rice University Start Up to D.N. The CCBTP training grant from the CPRIT funded V.S. and the Odessy Fellowship (MDACC) funded T.M.
PY - 2014/6
Y1 - 2014/6
N2 - Background & Aims The cause of hepatic failure in the terminal stages of chronic injury is unknown. Cellular metabolic adaptations in response to the microenvironment have been implicated in cellular breakdown. Methods To address the role of energy metabolism in this process we studied mitochondrial number, respiration, and functional reserve, as well as cellular adenosine-5′- triphosphate (ATP) production, glycolytic flux, and expression of glycolysis related genes in isolated hepatocytes from early and terminal stages of cirrhosis using a model that produces hepatic failure from irreversible cirrhosis in rats. To study the clinical relevance of energy metabolism in terminal stages of chronic liver failure, we analyzed glycolysis and energy metabolism related gene expression in liver tissue from patients at different stages of chronic liver failure according to Child-Pugh classification. Additionally, to determine whether the expression of these genes in early-stage cirrhosis (Child-Pugh Class A) is related to patient outcome, we performed network analysis of publicly available microarray data obtained from biopsies of 216 patients with hepatitis C-related Child-Pugh A cirrhosis who were prospectively followed up for a median of 10 years. Results In the early phase of cirrhosis, mitochondrial function and ATP generation are maintained by increasing energy production from glycolytic flux as production from oxidative phosphorylation falls. At the terminal stage of hepatic injury, mitochondria respiration and ATP production are significantly compromised, as the hepatocytes are unable to sustain the increased demand for high levels of ATP generation from glycolysis. This impairment corresponds to a decrease in glucose-6-phosphatase catalytic subunit and phosphoglucomutase 1. Similar decreased gene expression was observed in liver tissue from patients at different stages of chronic liver injury. Further, unbiased network analysis of microarray data revealed that expression of these genes was down regulated in the group of patients with poor outcome. Conclusions An adaptive metabolic shift, from generating energy predominantly from oxidative phosphorylation to glycolysis, allows maintenance of energy homeostasis during early stages of liver injury, but leads to hepatocyte dysfunction during terminal stages of chronic liver disease because hepatocytes are unable to sustain high levels of energy production from glycolysis.
AB - Background & Aims The cause of hepatic failure in the terminal stages of chronic injury is unknown. Cellular metabolic adaptations in response to the microenvironment have been implicated in cellular breakdown. Methods To address the role of energy metabolism in this process we studied mitochondrial number, respiration, and functional reserve, as well as cellular adenosine-5′- triphosphate (ATP) production, glycolytic flux, and expression of glycolysis related genes in isolated hepatocytes from early and terminal stages of cirrhosis using a model that produces hepatic failure from irreversible cirrhosis in rats. To study the clinical relevance of energy metabolism in terminal stages of chronic liver failure, we analyzed glycolysis and energy metabolism related gene expression in liver tissue from patients at different stages of chronic liver failure according to Child-Pugh classification. Additionally, to determine whether the expression of these genes in early-stage cirrhosis (Child-Pugh Class A) is related to patient outcome, we performed network analysis of publicly available microarray data obtained from biopsies of 216 patients with hepatitis C-related Child-Pugh A cirrhosis who were prospectively followed up for a median of 10 years. Results In the early phase of cirrhosis, mitochondrial function and ATP generation are maintained by increasing energy production from glycolytic flux as production from oxidative phosphorylation falls. At the terminal stage of hepatic injury, mitochondria respiration and ATP production are significantly compromised, as the hepatocytes are unable to sustain the increased demand for high levels of ATP generation from glycolysis. This impairment corresponds to a decrease in glucose-6-phosphatase catalytic subunit and phosphoglucomutase 1. Similar decreased gene expression was observed in liver tissue from patients at different stages of chronic liver injury. Further, unbiased network analysis of microarray data revealed that expression of these genes was down regulated in the group of patients with poor outcome. Conclusions An adaptive metabolic shift, from generating energy predominantly from oxidative phosphorylation to glycolysis, allows maintenance of energy homeostasis during early stages of liver injury, but leads to hepatocyte dysfunction during terminal stages of chronic liver disease because hepatocytes are unable to sustain high levels of energy production from glycolysis.
KW - Acute-in-chronic liver failure
KW - Adenosine-5′-triphosphate
KW - Decompensated liver cirrhosis
KW - Glycolysis
KW - Hepatocytes
KW - Mitochondria
UR - http://www.scopus.com/inward/record.url?scp=84901233996&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84901233996&partnerID=8YFLogxK
U2 - 10.1016/j.jhep.2014.02.014
DO - 10.1016/j.jhep.2014.02.014
M3 - Article
C2 - 24583248
AN - SCOPUS:84901233996
SN - 0168-8278
VL - 60
SP - 1203
EP - 1211
JO - Journal of Hepatology
JF - Journal of Hepatology
IS - 6
ER -